Aurinia Reports Second Quarter and Six Months 2022 Financial and Operational Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Aurinia Reports Second Quarter and Six Months 2022 Financial and Operational Results

Aurinia Pharmaceuticals (AUPH) Misses Q2 EPS by 3c

August 4, 2022 6:09 AM EDT

Aurinia Pharmaceuticals (NASDAQ: AUPH) reported Q2 EPS of ($0.25), $0.03 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $28.2 million versus the consensus estimate of $27.04 million.

GUIDANCE:

Aurinia Pharmaceuticals sees FY2022 revenue of $115-135 million, versus the consensus of... More